Christine Mikail Cvijic Neoleukin Therapeutics, Inc. (NLTX) insider trading activity

NLTX Quotes by TradingView

Christine Mikail Cvijic is President and CFO of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 72,343 shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Mar 13, 2025, when has been sold 4,501 shares (Common Stock) at a price of $16.94 per share, resulting in proceeds of $76,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.3K
5.86% 3M change
36.9% 12M change
Total Value Held $0

Christine Mikail Cvijic Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2025
SELL
Open market or private sale
$76,246 $16.94 p/Share
4,501 Reduced 5.86%
72,343 Common Stock
Nov 22 2024
BUY
Open market or private purchase
$491,520 $20.48 p/Share
24,000 Added 23.8%
76,844 Common Stock
Mar 13 2024
BUY
Grant, award, or other acquisition
-
31,903 Added 37.64%
52,844 Common Stock
CMC

Christine Mikail Cvijic

President and CFO
New York, NY

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NLTX